Burning mouth syndrome: the efficacy of lipoic acid on subgroups
Weight loss plateau on tirzepatide Plateaus happen with every weight loss medication
When both medications are active in your system, distinguishing the source of gastrointestinal symptoms becomes challenging, and patients may struggle to eat or stay hydrated during illness
Risk levels for drinking established by the WHO, which are now used in FDA clinical trials for AUD therapies, were also noted to decline by two levels in the semaglutide group after 26 weeks of therapy
Other causes include a genetic predisposition, a high number of pigmented nevi, and a fair complexion (223, 224)
Currently, there are no completed large-scale clinical trials specifically evaluating Mounjaro's effect on Alzheimer's disease or cognitive decline in humans